Trials / Withdrawn
WithdrawnNCT00441181
Effects of Travoprost on Neovascular Glaucoma
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Federal University of São Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost |
Timeline
- Start date
- 2008-01-01
- Completion
- 2008-12-01
- First posted
- 2007-02-28
- Last updated
- 2011-06-22
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00441181. Inclusion in this directory is not an endorsement.